The IPO Buzz: Cargo Therapeutics (CRGX) Launches $300 Million IPO
Phase 2 cancer clinical biotech CARGO Therapeutics (CRGX proposed) launched its $300 million IPO early today (Monday, Nov. 6, 2023) by disclosing terms: 18.75 million shares at $15.00 to $17.00. The IPO is expected to price Thursday night, Nov. 9, 2023, to trade Friday, Nov. 10, on the NASDAQ. If CARGO Therapeutics prices its IPO […]
November 6, 2023 Read More